Charles Quesenberry to Neoplasms
This is a "connection" page, showing publications Charles Quesenberry has written about Neoplasms.
Connection Strength
1.367
-
Spousal concordance for cancer incidence: A cohort study. Cancer. 1999 Dec 01; 86(11):2413-9.
Score: 0.123
-
A Randomized Controlled Trial of mHealth Mindfulness Intervention for Cancer Patients and Informal Cancer Caregivers: A Feasibility Study Within an Integrated Health Care Delivery System. Integr Cancer Ther. 2019 Jan-Dec; 18:1534735419850634.
Score: 0.116
-
Cancer among spouses: review of 195 couples. Cancer. 1998 Sep 01; 83(5):1055.
Score: 0.113
-
Case-control evaluation of screening. J Clin Epidemiol. 1996 Mar; 49(3):390-1; author reply 391-2.
Score: 0.095
-
Survival among HIV-infected and HIV-uninfected individuals with common non-AIDS-defining cancers. Cancer Epidemiol Biomarkers Prev. 2015 Aug; 24(8):1167-73.
Score: 0.089
-
Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons. AIDS. 2012 Nov 13; 26(17):2223-31.
Score: 0.076
-
The epidemiology of herpes zoster in patients with newly diagnosed cancer. Cancer Epidemiol Biomarkers Prev. 2013 Jan; 22(1):82-90.
Score: 0.076
-
HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiol Biomarkers Prev. 2011 Dec; 20(12):2551-9.
Score: 0.071
-
Cohort study of pioglitazone and cancer incidence in patients with diabetes. Diabetes Care. 2011 Apr; 34(4):923-9.
Score: 0.068
-
Availability and accuracy of medical record information on language usage of cancer patients from a multi-ethnic population. J Immigr Minor Health. 2010 Aug; 12(4):480-8.
Score: 0.065
-
Screening pharmaceuticals for possible carcinogenic effects: initial positive results for drugs not previously screened. Cancer Causes Control. 2009 Dec; 20(10):1821-35.
Score: 0.062
-
HIV infection and the risk of cancers with and without a known infectious cause. AIDS. 2009 Nov 13; 23(17):2337-45.
Score: 0.062
-
Epidemiologic evaluation of pharmaceuticals with limited evidence of carcinogenicity. Int J Cancer. 2009 Nov 01; 125(9):2173-8.
Score: 0.061
-
Erratum: Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361 859 recipients. Pharmacoepidemiol Drug Saf. 2008 Jul; 17(7):751.
Score: 0.056
-
Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361,859 recipients. Pharmacoepidemiol Drug Saf. 2008 Jan; 17(1):27-36.
Score: 0.054
-
Methylphenidate use in children and risk of cancer at 18 sites: results of surveillance analyses. Pharmacoepidemiol Drug Saf. 2007 Dec; 16(12):1268-72.
Score: 0.054
-
Social class, race/ethnicity, and incidence of breast, cervix, colon, lung, and prostate cancer among Asian, Black, Hispanic, and White residents of the San Francisco Bay Area, 1988-92 (United States). Cancer Causes Control. 1999 Dec; 10(6):525-37.
Score: 0.031
-
Marijuana use and cancer incidence (California, United States). Cancer Causes Control. 1997 Sep; 8(5):722-8.
Score: 0.026
-
Recent Trends in Cardiovascular Mortality in the United States and Public Health Goals. JAMA Cardiol. 2016 08 01; 1(5):594-9.
Score: 0.025
-
Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes. JAMA. 2015 Jul 21; 314(3):265-77.
Score: 0.023
-
Agreement between self-reported early cancer detection practices and medical audits among Hispanic and non-Hispanic white health plan members in northern California. Prev Med. 1995 May; 24(3):278-85.
Score: 0.022